ADVISORY RESEARCH INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$217,553
-82.9%
4,332
-68.7%
0.03%
+30.4%
Q1 2018$1,269,000
-21.7%
13,834
-35.6%
0.02%
-14.8%
Q4 2017$1,620,000
+36.2%
21,480
+25.9%
0.03%
+42.1%
Q3 2017$1,189,000
-13.5%
17,065
-37.1%
0.02%
-13.6%
Q2 2017$1,375,00027,1370.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders